Bozic Carmen 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 31, 2024
Insider Transaction Report
Form 4
Bozic Carmen
EVP and CMO
Transactions
- Sale
Common Stock
2024-05-29$445.56/sh−2,280$1,015,877→ 34,659 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024.